HonorHealth First in Arizona to Deploy Perimeter's Groundbreaking Visualization Technology in Surgery
TORONTO and DALLAS, April 30, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company") announced today that HonorHealth, a leading healthcare system serving more than five million people in the greater Phoenix and Scottsdale areas, is the first in Arizona to deploy the Company's S- Series OCT (Optical Coherence Tomography) technology to visualize tissue margins in the operating room ("OR").
"Having the most advanced technologies in the operating room to assist my decision-making in real-time is incredibly valuable," said Dr. Sommer Gunia, a breast surgical oncologist with HonorHealth. "OCT imaging technology allows me to see at a depth and resolution that was previously impossible in the OR, and it has become an important tool that helps me achieve the best possible outcomes for my patients."
Traditional technologies such as X-ray, ultrasound or magnetic resonance imaging ("MRI") don't have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either confirm clean margins or show positive margins, which often result in patients returning for another procedure. The resolution of the S-Series OCT is optimized down to 2 mm for identifying regions of interest in tissue microstructures and features such as blood vessels, ducts and glands, making it ideal for visualizing surgical margins and helping surgeons to make the best surgical decisions for their patients. It uses light to create cross-sectional 3D images of tissue microstructures at 10 times the resolution of ultrasound and X-ray and 100 times the resolution of MRI. The S-Series OCT was cleared by the U.S. Food and Drug Administration in 2021 for general tissue imaging.
"HonorHealth's adoption of the S-Series OCT continues our nationwide commercial expansion and increases patient access to the technology in one of the most populous metropolitan areas in the Southwest," said Perimeter CEO Adrian Mendes. "The ongoing adoption of our S-Series OCT reflects both the need for enhanced margin visualization in the operating room and confidence in our technology to improve patient outcomes. We are thrilled to partner with HonorHealth."
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that was recently evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.
S-Series OCT Intended Use and Unapproved Uses
The S-Series OCT is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization with image review manipulation software for identifying and annotating regions of interest. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit www.perimetermed.com/disclosures.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, statements regarding the anticipated terms and jurisdictions of the Offering; securities offered thereunder; the timing of the Offering, including the anticipated Closing Date; use of proceeds from the Offering; fees anticipated to be paid to the Agent and terms thereof; regulatory and exchange approvals, including the listing of the common shares offered pursuant to the Offering on the TSXV, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Annual Information Form for the year ended December 31, 2024, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
Contacts
Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: [email protected]
Susan Thomas
Media Relations
Direct: 619-540-9195
Email: [email protected]
Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: [email protected]
SOURCE Perimeter Medical Imaging AI Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
5 hours ago
- Globe and Mail
Is American Express Worth Buying Right Now?
American Express (NYSE: AXP) is one of the stocks owned by Warren Buffett within Berkshire Hathaway 's stock portfolio. That fact alone is enough to get some investors to buy the stock. However, you really need to consider other factors, like the business behind the stock, as well as its price tag. Here's a look at whether American Express is worth buying right now. American Express has a great business American Express is a financial giant, acting largely as a payment processor. The company's logo adorns credit cards that get used in retail establishments and online. Each transaction generates fee income for American Express. It issues its own cards, too, so it generates card/membership fees directly from customers there, as well. One differentiation between American Express and its peers is that Amex, as it is often called, focuses on more affluent customers. Wealthier consumers tend to be more resilient during economic downturns. Basically, they have the money to keep spending even as less affluent consumers hunker down. That means that Amex's business will usually perform relatively well during recessions and other periods of economic uncertainty. So far, 2025 has been filled with uncertainty. From tariff fights to stock market corrections, the news has been filled with negative headlines. In fact, American Express' stock price fell along with the S&P 500 (SNPINDEX: ^GSPC) earlier in the year. And it has recovered along with the index as well, as investors regained confidence. What's notable, however, is that American Express' price moves have been more dramatic than the market's moves. AXP data by YCharts American Express is still below its high-water mark That's an interesting sign, since it could mean that Amex's stock has more recovery potential ahead of it. Given the strength of its business model, that isn't an unreasonable assessment. However, there's also a negative way to view the price swing. It could very well be that investors got overly enthusiastic about the business and bid the price up to unrealistic levels earlier in the year. And the return toward those levels just indicates that investors are, again, being overzealous with their expectations. A look at traditional valuation metrics, perhaps unfortunately, suggests the second explanation is the more likely one. American Express' price-to-sales ratio is currently around 3.1, compared to a five-year average of 2.6. The price-to-earnings (P/E) ratio is currently about 20.5, versus a longer-term average of just under 19. And the price-to-book value ratio is 6.6 today, compared to a five-year average of roughly 5. All three metrics suggest that American Express is expensive today. And they are buttressed by a nontraditional valuation tool: dividend yield, which falls as share price rises. American Express' dividend yield is about 1.1% today. Not only is that less than the already miserly 1.3% yield you could collect from the S&P 500 index, but it is also near the lowest levels of the past decade. Again, the direction is pretty clear: Amex looks expensive. American Express is a great business There's a reason Warren Buffett owns American Express. It is a well-run business with some clear advantages over its peers. Buffett didn't just buy Amex -- he's owned it for many years. And sticking with a good company is part of Buffett's investment approach. However, Buffett's mentor, Benjamin Graham, made an important observation that investors looking at American Express today should heed: Even great companies can be bad investments if you pay too much for them. And it looks like American Express is too expensive right now. Should you invest $1,000 in American Express right now? Before you buy stock in American Express, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and American Express wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
Globe and Mail
9 hours ago
- Globe and Mail
2 Artificial Intelligence (AI) Stocks to Buy Before They Soar to $3 Trillion, According to Certain Wall Street Analysts
Shares of Amazon (NASDAQ: AMZN) and Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) have fallen a few percentage points year to date despite a 2% return in the benchmark S&P 500 (SNPINDEX: ^GSPC). But certain Wall Street analysts anticipate substantial gains in those stocks in the next 12 months, as detailed below: Ivan Feinseth at Tigress Financial has set Amazon with a target price of $305 per share. That implies 44% upside from its current share price of $212. It also implies a market value of $3.2 trillion. Paul Chew at Phillip Securities has set Alphabet with a target price of $250 per share. That implies 45% upside from its current share price of $172. It also implies a market value of $3 trillion. Here's what investors should know about Amazon and Alphabet. Amazon: 44% implied upside The investment thesis for Amazon centers on its strong position in three growing markets. It runs the most popular online marketplace outside of China, powering nearly 41% of retail e-commerce sales in the United States. Amazon is also the largest retail media company, collecting nearly 77% of domestic-retail ad spending and 40% of global-retail ad spending. Finally, Amazon Web Services (AWS) is the largest public cloud, holding 29% market share in infrastructure and platform services. With more customers and partners than any other cloud platform, AWS is particularly well positioned to capitalize on growing demand for artificial intelligence (AI) infrastructure. The company has leaned into that opportunity by developing custom chips for training and inference. Importantly, Amazon is also using AI across its retail business to improve productivity and efficiency. CEO Andy Jassy says the company is developing about 1,000 generative AI tools to make warehouse robots smarter, improve inventory allocation, and optimize delivery routes. Those innovations, coupled with the ongoing restructuring of its logistics network, should improve retail margins in the coming years. As a caveat, Amazon may struggle with tariffs. Morgan Stanley estimates 60% of sellers on the marketplace have some exposure to China, and Chinese sellers represent an important source of advertising revenue. Nevertheless, Andy Jassy believes its diversified seller base will let the company "weather challenging conditions better than others." Wall Street expects Amazon's earnings to increase at 10% annually through 2026. That makes the current valuation of 34 times earnings look expensive. But analysts have often missed the mark in the past. Amazon beat the consensus earnings estimate by an average of 21% in the last six quarters. Assuming that trend continues, the current stock price is quite reasonable. Here's the takeaway: I'm not convinced Amazon stock will return 44% in the next year, but I still think patient investors should own a position, and now is a reasonable time to buy a few shares. Alphabet: 45% implied upside The investment thesis for Alphabet centers on large opportunities in digital advertising and cloud services. Namely, Alphabet is the largest ad tech company on the planet, and digital ad spending is forecast to grow at 15% annually through 2030. While Alphabet has been losing market share for years, it still has a profound ability to engage internet users with platforms like Chrome, Google Search, and YouTube. Also, while internet search is undoubtedly moving toward AI tools like ChatGPT and Perplexity, Alphabet is successfully leaning into that trend. Generative AI overviews in Google Search are driving higher usage and satisfaction. And its generative AI application Gemini was the second-most downloaded AI chatbot behind ChatGPT last year, according to Sensor Tower. Google is the third-largest public cloud. It accounted for 12% of infrastructure and platform-services spending in the first quarter, up a percentage point from the prior year. Meanwhile, Amazon and Microsoft lost share. Google may continue to outpace its peers due to strength in large language models and AI infrastructure, two categories where Forrester Research has recognized the company as a leader. Importantly, Alphabet has a third major opportunity in autonomous driving technology. That industry is far less developed than digital advertising and cloud computing, but the global autonomous ride-sharing market could top $2 trillion over the next decade, according to Evercore. Alphabet's Waymo is an early leader. It currently provides 250,000 driverless rides per week across four U.S. cities, up fivefold from last year. As a caveat, Alphabet faces a possible breakup depending on the outcome of two antitrust lawsuits that have progressed to the remediation phase. A federal judge will propose fixes for its illegal internet search monopoly in August, and another federal judge will rule on its ad tech monopoly at a future date. Most analysts think the probability of a forced breakup is slim, but the odds are not zero. With that in mind, Wall Street estimates Alphabet's adjusted earnings will increase at 7% annually through 2026. That makes the current valuation of 19 times sales look somewhat expensive. But Alphabet beat the consensus estimate by an average of 14% during the last six quarters. The current valuation would be reasonable if that trend continues. Here's the takeaway: Alphabet stock could return 45% in the next year if the judges issue favorable rulings in the antitrust cases. But the stock could also decline sharply if either judge orders a breakup. Investors can buy a small position today, but I would wait for more clarity before taking a large stake. Should you invest $1,000 in Amazon right now? Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Trevor Jennewine has positions in Amazon. The Motley Fool has positions in and recommends Alphabet and Amazon. The Motley Fool has a disclosure policy.
Winnipeg Free Press
10 hours ago
- Winnipeg Free Press
TACO time
Opinion The stock market says, 'Yes.' And the bond market says, 'No.' This sums up much of the recent sentiment about the economy in the United States, and for that matter the global economy, amid the back-and-forth policies of U.S. President Donald Trump. Stocks have largely recovered their losses this year, as investors believe the One Big Beautiful Bill Act — with its tax cuts largely focused on the wealthy — will power a surge in growth. Michael Probst / The Associated Press files The curve of the German stock index DAX is seen in the background as U.S. President Donald Trump is shown on a TV screen at the stock market in Frankfurt, Germany. What's more, many investors ascribe to 'TACO', a term coined by a Financial Times columnist that stands for 'Trump always chickens out,' meaning most of the tariffs threats are bluster meant to make him appear to be a master deal-maker and they won't be here to stay. 'That is quite a diverging opinion from what the bond market is saying,' says Jonathan Baird, Toronto-based editor and publisher of the Global Investment Letter. Bond investors view the One Big Beautiful Bill as a recipe for inflation, eventually adding more than US$3.8 trillion to the annual budget deficit. Tariffs, too, are inflationary, which further make the case for more investors to sell their U.S. bonds. Average investors, not Wall Street, are likely feeling indecisive and maybe even fearful. A dose of caution is warranted, says John De Goey, portfolio manager with Design Wealth Management in Toronto, and author of Stand Up to the Financial Services Industry. Even without Trump-induced mayhem, 'stocks are very expensive and therefore very risky.' He points to the cyclically adjusted price-to-earnings — or CAPE — for the S&P 500. CAPE helps determine if an investment — based on a 10-year average of inflation-adjusted earnings — is valued appropriately. Right now, the S&P 500 is highly overvalued, according to CAPE. De Goey says the metric may not be a good predictor of bear markets. 'But it's extremely reliable for determining what the annualized return will be for the asset class … over the next decade,' he says. 'So when the S&P 500 is in the 30s or higher, the return over the next decade has historically been around zero.' The CAPE for the world's largest stock index has been about 35 in recent weeks. What's more, many seasoned investors see a decade ahead that could be similar to the 1970s when 'stagflation' weighed on markets. Characterized by higher than normal inflation and slow economic growth, stagflation can be toxic for stock and bond returns. 'I would suggest probably being as defensive as you're comfortable being,' says Baird, who expects stagflation to be a problem for the next few years. He doesn't recommend moving all of the portfolio to cash to preserve capital. That is tricky to time correctly on getting out of the market and, even more so, getting back into the market. Broadly, stagflation fighting strategies should focus less on growth stocks. Instead, consider companies selling goods and services consumers can't go without — like groceries and housing. Bonds should have shorter durations to reduce the impact of inflation. Commodity- and currency-based strategies can also provide some upside amid volatility. As well, alternative investments — private equity and credit, private real estate and hedge funds — are increasingly used by portfolio managers. 'The low-hanging fruit is increasing alternatives exposure,' De Goey says, noting these assets are less correlated to stock and bond markets, providing portfolio stability. Previously only available to wealthy investors, alternatives are now widely available as mutual funds and exchange-traded funds (ETFs). That said, investors should still own stocks, including those in the U.S., but they should consider reducing exposure to overvalued companies like the so-called Magnificent Seven (including Amazon Inc., Tesla Inc., Apple Inc. and Meta Inc.), says Jai Gandhi, investment adviser with Endeavour Wealth Management, iA Private Wealth in Winnipeg. 'We're not cutting our weight to the U.S. market compared with a year ago, but we're conscious of the high values of companies that hold more risk.' That said, owning good companies never goes out of style for long-term investors. 'We don't worry too much about short-term price movements,' says Hardev Bains, president and chief investment officer at Lionridge Capital Management in Winnipeg. Rather, the focus for Bains and other fundamental investors is owning companies with long-term profitability growth, strong balance sheets (significantly more assets than liabilities) and competitive advantages. These companies, however, are only purchased when their share price reflects fair value relative to those qualities. What's more, even holding great companies can be risky when they become steeply overvalued. At that point, it's worthwhile selling those holdings or at least reducing their portion in the portfolio. 'Part of our discipline is if we sell companies and can't find anything to buy — which happens in periods of expensive markets — we go to cash, as we're doing right now,' Bains says Companies may have great business models, but their share price today is generally too high to purchase with a margin of safety. Still, Lionridge's equity portfolio obviously must hold stocks — currently about 20 companies that are likely to weather stagflation and even a recession better than other stocks. A recession is likely already underway, De Goey notes, pointing to gross domestic product (GDP) in the first quarter contracting in the U.S. 'No reasonable person expects the economy to grow in Q2 given tariffs are now having more of an impact.' Monday Mornings The latest local business news and a lookahead to the coming week. The best companies should remain profitable, and market drops will put their shares on sale from time to time, Baird says. In the meantime, beware of FOMO — fear of missing out — when markets surge higher, he adds. That often leads to buying high and, worse, selling low in a knee-jerk reaction to markets plunging in fear. 'We're all fallible and prone to psychological traps,' Baird adds. 'So the biggest thing for any investor is managing our emotions.' Joel Schlesinger is a Winnipeg-based freelance journalist joelschles@
